Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 3
Journal homepage
34
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy

Takeshi KurodaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, JapanCorrespondence[email protected]
,
Shintaro HiroseDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Naohito TanabeDivision of Health Promotion, Niigata University Graduate School of Medical and Dental Sciences,Niigata, Japan
,
Hiroe SatoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Takeshi NakatsueDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Jyunya AjiroDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Yoko WadaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Syuichi MurakamiDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Hisashi HasegawaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Satoshi ItoDepartment of Internal Medicine, University of Tsukuba,Tsukuba, Japan
,
Minoru SakatsumeDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
,
Masaaki NakanoDepartment of Medical Technology, School of Health Sciences, Faculty of Medicine, Niigata University,Niigata, Japan
&
Fumitake GejyoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences,1-757, Asahimachi-dori, Niigata 951-8510, Japan
 show all
Pages 206-212 | Received 11 Sep 2006, Accepted 05 Feb 2007, Published online: 02 Jan 2014

References

  • Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Matsuda T. Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo) 1974;27:775–84.
  • Ishikawa H. Mizolobine and mycophenolate mofetil. Curr Med Chem 1999;6:575–97.
  • Gerber DA, Bonham CA, Thomson AW. Immunosuppressive agents: recent development in molecular action and chemical ap-plication. Transplant Proc 1998;1:89–90.
  • Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cel-lular and molecular mechanisms of action. Am J Kidney Dis 1996;28:159–72.
  • Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996;36:1081–92.
  • Kokado Y, Ishibashi I, Jiang H. Low dose cyclosporine, mizoribine and prednisolone in renal transplantation: a new triple therapy. Clin Transplant 1990;4:191–7.
  • Inoue T, Kusaba R, Takahashi I, Sugumoto H, Kuzuhara K, Yamada Y, et al. Clinical trial of bredinine in renal transplantation. Transplant Proc 1981;13:315–8.
  • Shiokawa Y, Akizuki R, Yokohari R, Hashimoto H, Kashiwazaki S, Kondo H, et al. Clinical evaluation of mizoribine on rheumatoid arthritis: a double-blind comparative study using lobenzariddiso-dium as a standard drug (in Japanese). Igakunoayumi 1991;156: 811–31.
  • Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, et al. A multicenter trial of mizoribine compared with placebo in children with frequency relapsing nephritic syndrome. Kidney Int 2000;58:317–24.
  • Kaneko K, Nagaoka R, Ohtomo Y, Yamashiro Y. Mizoribine for childhood IgA nephropathy. Nephron 1999;83:376–7.
  • Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, et al. Mizoribine as an effective combined maintenance therapy with prednisolone in childhood-onset systemic lupus erythemato-sus. Pediatr Int 1999;19:2–11.
  • Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Wada S. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 2003;60:390–4.
  • Fukunishi T, Takahashi S, Hashinaka Y, Oota K, Nagano S, Takada K, et al. Bredinine concentration in blood and immunosup-pressive effect (in Japanese) Ishyoku Jpn J Transplant 1982;17 Supp1:750–2.
  • Sonda K, Takahashi K, Tanabe K, Funchinose S, Hayasaka Y, Kawaguchi H, et al. Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 1996;28:3643–8.
  • Kusaba R, Otubo 0, Inou T, Yujino M, Ishikawa H. Studies on pharmacokinetics of bredinin (in Japanese with an English ab-stract). Isyoku 1982:17 Supp1:585–93.
  • Koshikawa S, Satou M, Narita K, Sakai N, Shiiya T, Koide T, et al. Clinical study of HE-69 (miziribine) on patients with incur-able nephritic syndrome - a multicenter open study (in Japanese). Kidney Dial 1987;23:971–80.
  • Warabi H, Abe S, Kondo H, Ishikawa Y, Sugawara S, Shichikawa K, et al. Consecutive administration of mizoribine in rheumatoid arthritis: pharmacokinetic study (in Japanese with an English ab-stract). Ftheumatology 1991;5:287–300.
  • Honma M, Yoichi I, Akizuki M, Kashiwazaki S, Kondo H, Hashi-moto H, et al. Late phase 2 study of U67, 590A pulse therapy for lupus nephritis: dose finding study (in Japanese). Kisotorinsyo 1993;27: 5191–225.
  • Honma M, Akizuki R, Yokohari R, Hashimoto H, Kashiwazaki S, Kondo H, et al. Clinical evaluation of mizoribine on lupus nephri-tis: multicenter single-blind comparative study with inactive pla-cebo (in Japanese). Ftinsyo-Igaku 1989;5:795–824.
  • Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E. Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int 2003;45:488–90.
  • Tokuda M, Dobashi H, Hiraishi T, Mitsunaka H, Takahashi J, Hirohata M. Effect of mizoribine pulse therapy on the disease ac-tivity of rheumatoid arthritis refractory to the treatment with methotrexate. Ftheumatology 1998;20:525–6.
  • Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, et al. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephritic syndrome. Tohoku J Exp Med 2005;205:87–91.
  • Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H. Mizoribine oral pulse therapy for steroid-dependent nephritic syndrome. Pediatr Nephrol 2005;20:96–8.
  • Takei S. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Pediatr Int 2002;44:205–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.